- Global Pharma News & Resources

Americas GERD NERD Treatment Market Showcase Blooming CAGR 4.02% In Market Forecast Till 2023

Americas GERD amp; NERD treatment market is anticipated to grow at the CAGR of 4.02% during the forecast period 2017-2023.

The Americas GERD amp; NERD treatment market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2017 to 2023. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2017 to 2023.

We can provide sample pages for a better understanding of this report.
Request Sample of This Report @

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the Americas GERD amp; NERD treatment market.

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market.

The market is studied for regions such as North America (U.S., and Canada), Europe (U.K., Germany, France, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East amp; Africa (GCC, South Africa, and Rest of Middle East amp; Africa).

Key Takeaways:

What is the market size in 2018 and the growth rate of the Americas GERD amp; NERD treatment market?

What is the market drivers, restrains, opportunities governing the Americas GERD amp; NERD treatment market?

Which are the largest and the fastest growing segments in the Americas GERD amp; NERD treatment market?

Who are the key players operating in the market and their market position?

What is the pipeline scenario, drug pricing analysis and technological development in the market?

View Detail Report With Complete Table Of Content@

Gerd amp; Nerd Treatment Market Information, By Drug Class (Antacids (Acid Neutralizers), Proton Pump Inhibitors, H2 Receptor Blocker), Dosage Form (Solid and Liquid), End User (Hospitals amp; Clinics, Research Centers, And Others) - Americas Forecast Till 2023

Market Analysis

In the course of the last two hundred years, indigestion has been one of the common health issues in the U.S. However, a definitive objective of the gastroesophageal reflux treatment has dependably continued as before, which is to stifle the side effects of the GERD patient. GERD influences up to 40% of the U.S. populace in their lifetime and currently, most of the people are facing this health condition. If the GERD isn't appropriately overseen, it can prompt Barrett's esophagus. Early treatment of Barrett's esophagus is significant in light of the fact that it is the essential risk factor for esophageal cancer. The frequency of indigestion issue, otherwise called acid reflux, is quickly expanding around the world. According to various studies almost each individual experiences acid reflux at least once in their lifetime. GERD is one of the regularly watched intermittent gastrointestinal disorders around the world. The Americas GERD amp; NERD treatment market is anticipated to grow at the CAGR of 4.02% during the forecast period 2017-2023.

This issue not just affects the health and nature of patient lives yet, in addition, stretches out to the healthcare economy and system.

The real driving elements for the development of the market are expanding instances of smoking, rising instances of reflux issue amid pregnancy, evolving way of life, and sporadic dietary propensities. In addition, expanding occurrence of indigestion issue (acid reflux), developing geriatric populace is probably going to fuel the market development.

Market Segmentation

The Americas GERD amp; NERD treatment market is classified on the basis of its drug class, end user, dosage form, and regional analysis.

Based on its drug class, the market is bifurcated into proton pump inhibitors, antacids (acid neutralizers), H2 receptor blocker, antidepressants, prokinetic agents, calcium channel blockers, among others. On the basis of its dosage form, the Americas GERD amp; NERD treatment market is divided into liquid and solid. Based on its end-user industry, the global market is segmented into research centers, hospitals amp; clinics, and others.

Regional Analysis

Geographically, the Americas GERD amp; NERD treatment market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Industry Players

The list of major players in the Americas GERD amp; NERD treatment market include companies like AstraZeneca Plc (U.K), Cempra Inc. (U.S.), Boston Scientific Corporation (U.S.), Eisai Co., Ltd. (Japan), EndoStim Inc. (U.S.), EndoGastric Solutions Inc. (U.S.), GlaxoSmithKline Plc (U.K), Jeil Pharmaceutical Co. Ltd. (South Korea), Ironwood Pharmaceuticals, Inc. (U.S.), Johnson amp; Johnson (U.S.), Medigus Ltd. (Israel), Mederi Therapeutics Inc. (U.S.), Medtronic Inc. (U.S.), Valeant Pharmaceuticals International, Inc. (Canada), Allegiant health (U.S.), Tya pharmaceuticals (U.S.), among others.

Table Of Contents

Gerd amp; Nerd Treatment Market Information, By Drug Class, Dosage Form, End User - Americas Forecast Till 2023

1 Report Prologue

2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations

3 Research Methodology
3.1.1 Primary Research Methodology
3.1.2 Data Points Received from the Doctors/ Gastrologist:
3.1.3 Data points received from the Manufacturer/ Pharmaceutical Companies:
3.1.4 Data points received from Hospitals, Clinics:
3.1.5 Secondary Research Methodology
3.1.6 Market Share Analysis
3.1.7 Trade Analysis
3.1.8 Market Pricing Approach

4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing cases of smoking to boost the market growth (Impact weightage- 20%)
4.2.2 Rising cases of reflux disorder during pregnancy (impact weightage- 15%)
4.2.3 Changing lifestyle and irregular dietary habits (Impact weightage- 15%)
4.2.4 Increasing incidence of acid reflux disorder (heartburn) will boost the American GERDamp; NERD treatment market (Impact weightage- 25%)
4.2.5 Growing geriatric population (impact weightage- 15%)
4.2.6 Increasing demands for endoscopy biopsy procedures for early diagnosis (Impact weightage- 10%)
4.3 Restraints
4.3.1 Loss of patent exclusivity and lack of pipeline drugs (impact weightage- 55%)
4.3.2 High cost of the gastroscopes (weightage impact- 45%)
4.4 Opportunity
4.4.1 Development of new drugs
4.5 Mega Trends
4.6 Macroeconomic Indicators
4.7 Technology Trends amp; Assessment

5 Market Factor Analysis
5.1 Porters Five forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.2.1 Ramp;D
5.2.2 Manufacturing
5.2.3 Distribution amp; Sales
5.2.4 Post-Sales Monitoring
5.3 Demand amp; Supply: Gap Analysis
5.4 Pricing Analysis
5.5 Investment Opportunity Analysis

6 Americas GERD amp; NERD Treatment Market, by Drug class
6.1 Introduction
6.2 Antacids (Acid Neutralizers)
6.3 Proton Pump Inhibitors
6.3.1 Esomeprazole
6.3.2 Omeprazole
6.3.3 Pantoprazole
6.3.4 Lansoprazole
6.3.5 Dexlansoprazole
6.3.6 Rabeprazole
6.4 H2 receptor blocker
6.4.1 Ranitidine
6.4.2 Famotidine
6.4.3 Cimetidine
6.4.4 Nizatidine
6.5 Pro kinetic agents
6.5.1 Domperidone
6.5.2 Metoclopramide
6.5.3 Itopride
6.5.4 Prucalopride
6.5.5 Cisapride
6.5.6 Benzamide
6.5.7 Mosapride
6.5.8 Erythromycin
6.6 Antidepressants
6.7 Calcium Channel Blockers

7 Americas GERD amp; NERD Treatment Market, by Dosage Form
7.1 Introduction
7.2 Solid
7.3 Liquid

8 Americas GERD amp; NERD Treatment Market, by End User
8.1 Introduction
8.2 Hospitals amp; Clinics
8.3 Research Centers

9 Americas GERD amp; NERD Treatment Market, by Region

10 Americas GERD amp; NERD Treatment Market, by Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 South America

11 Competitive Landscape
11.1 Introduction
11.2 Company Share Analysis

12 Company Profiles
12.1 AstraZeneca
12.1.1 Company Overview
12.1.2 Financials
12.1.3 Products
12.1.4 Strategy
12.1.5 Key Developments
12.2 Addex Pharmaceuticals
12.2.1 Company Overview
12.2.2 Financials
12.2.3 Products
12.2.4 Strategy
12.2.5 Key Developments
12.3 Takeda Pharmaceutical
12.3.1 Company Overview
12.3.2 Financials
12.3.3 Products
12.3.4 Strategy
12.3.5 Key Developments
12.4 Eisai Co., Ltd
12.4.1 Company Overview
12.4.2 Financials
12.4.3 Products
12.4.4 Strategy
12.4.5 Key Developments
12.5 Medigus Ltd
12.5.1 Company Overview
12.5.2 Financials
12.5.3 Products
12.5.4 Strategy
12.5.5 Key Developments
12.6 RaQualia Pharma Inc
12.6.1 Company Overview
12.6.2 Financials
12.6.3 Products
12.6.4 Strategy
12.6.5 Key Developments
12.7 Torax Medical
12.7.1 Company Overview
12.7.2 Financials
12.7.3 Products
12.7.4 Strategy
12.7.5 Key Developments
12.8 Carbon Medical technologies
12.8.1 Company Overview
12.8.2 Financials
12.8.3 Products
12.8.4 Strategy
12.8.5 Key Developments
12.9 Endogastric Solutions
12.9.1 Company Overview
12.9.2 Financials
12.9.3 Products
12.9.4 Strategy
12.9.5 Key Developments
12.1 Medtronic
12.10.1 Company Overview
12.10.2 Financials
12.10.3 Products
12.10.4 Strategy
12.10.5 Key Developments
12.11 Pfizer
12.11.1 Company Overview
12.11.2 Financials
12.11.3 Products
12.11.4 Strategy
12.11.5 Key Developments
12.12 Novartis AG.
12.12.1 Company Overview
12.12.2 Financials
12.12.3 Products
12.12.4 Strategy
12.12.5 Key Developments
12.13 GlaxoSmithKline plc
12.13.1 Company Overview
12.13.2 Financials
12.13.3 Products
12.13.4 Strategy
12.13.5 Key Developments
12.14 Valeant Pharmaceuticals
12.14.1 Company Overview
12.14.2 Financials
12.14.3 Products
12.14.4 Strategy
12.14.5 Key Developments
12.15 Ironwood Pharmaceuticals, Inc.
12.15.1 Company Overview
12.15.2 Financials
12.15.3 Products
12.15.4 Strategy
12.15.5 Key Developments

13 Appendix
13.1 Discussion Blue Print

14 Conclusion
14.1 Key Findings
14.1.1 From CEOrsquo;s View Point
14.1.2 Unmet Needs
14.2 Key companies to watch

Quick Buy This Premium Report From Here:

About Us:

Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.


Email: | +1 407 915 4157

Editor Details

Last Updated: 04-Jul-2019